Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Mylan/Pfizer's Upjohn Unit Merger on Track to Close in Q4

The pending merger of Pfizer's (PFE) Upjohn unit with Mylan (MYL) is on track to close in the fourth quarter of 2020 as almost all necessary regulatory clearances are in place.

PFE : 36.63 (-0.52%)
GILD : 65.05 (+0.02%)
MYL : 15.73 (-2.66%)
GSK : 39.26 (-0.53%)
Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL

and , /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that the Technical Board of Appeal of the European Patent Office (EPO) has held that Yeda Research and Development Company, Ltd.'s European...

MYL : 15.73 (-2.66%)
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn

, and , /PRNewswire/ -- Mylan  (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the European Commission (EC) for the proposed combination...

MYL : 15.73 (-2.66%)
PFE : 36.63 (-0.52%)
Mapi Pharma Presents Glatiramer Acetate Depot (GA Depot) Results at the 8th Joint ACTRIMS-ECTRIMS Meeting MSVirtual2020

90% of relapsing remitting multiple sclerosis (RRMS) patients on GA Depot demonstrated no evidence of disease activity (NEDA) at four years

MAPI : N/A (unch)
MYL : 15.73 (-2.66%)
Mylan to Buy Aspen Pharmacare's Thrombosis Business in Europe

Mylan (MYL) will acquire Aspen Pharmacare's thrombosis business in Europe and expand its complex injectables offering and presence in hospitals.

PFE : 36.63 (-0.52%)
MYL : 15.73 (-2.66%)
GSK : 39.26 (-0.53%)
TBPH : 17.82 (+1.14%)
Mylan Nv Set to Possibly Rebound After Yesterday's Selloff of 3.04%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $15.06 to a high of $15.67. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $15.35 on...

MYL : 15.73 (-2.66%)
After Yesterday's Decline of 3.04%, Mylan Nv Offers Investors Better Value

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $15.06 to a high of $15.67. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $15.35 on...

MYL : 15.73 (-2.66%)
Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

and , /PRNewswire/ -- Global pharmaceutical company  (NASDAQ: MYL) today announced that Executive Chairman , together with President will present at the Morgan Stanley Virtual 18th Annual Global Healthcare...

MS : 50.08 (-0.34%)
MYL : 15.73 (-2.66%)
Mylan to Present at the BofA Securities Virtual Global Healthcare Conference

and , /PRNewswire/ -- Global pharmaceutical company  (NASDAQ: MYL) today announced that Executive Chairman , together with President will present at the BofA Securities Virtual Global Healthcare Conference...

MYL : 15.73 (-2.66%)
Mylan to Acquire Aspen's Thrombosis Business in Europe

, and , /PRNewswire/ --  N.V. (NASDAQ: MYL) today announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis...

MYL : 15.73 (-2.66%)
Mylan (MYL) Down 3.7% Since Last Earnings Report: Can It Rebound?

Mylan (MYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MYL : 15.73 (-2.66%)
Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes

and PITTSBURGH and BENGALURU, , /PRNewswire/ --  (NASDAQ: MYL) and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced the U.S. launch of Semglee™...

MYL : 15.73 (-2.66%)
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up

and , /PRNewswire/ --  (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone...

MYL : 15.73 (-2.66%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mylan N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 25, 2020) - , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mylan N.V. (NASDAQ: MYL) ("Mylan" or...

MYL : 15.73 (-2.66%)
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mylan N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 24, 2020) - , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mylan N.V. (NASDAQ: MYL) ("Mylan"...

MYL : 15.73 (-2.66%)
ROSEN, A LEADING LAW FIRM, Reminds Mylan N.V. Investors of Important Tuesday Deadline in Securities Class Action - MYL

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mylan N.V. (NASDAQ: MYL) between February 16, 2016 and May 7, 2019, inclusive (the "Class Period"), of the important...

MYL : 15.73 (-2.66%)
TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mylan N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 21, 2020) - , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mylan N.V. (NASDAQ: MYL) ("Mylan"...

MYL : 15.73 (-2.66%)
New opportunities for Musculoskeletal Medicine Market with Sustained Growth and Expansion 2020-2026 | Mylan N.V., Teva Pharmaceutical Industries Ltd, UCB S.A.

Global Musculoskeletal Medicine Market, delivering a must-read report for industry stakeholders wanting to understand the strategic landscape of this increasing sector. Readers will find an in-depth analysis...

HKMPF : 34.5000 (unch)
VRX.TO : 30.80 (-3.33%)
MYL : 15.73 (-2.66%)
TEVA : 9.48 (+2.05%)
MRK : 85.81 (+0.20%)
ACOR : 0.5401 (-6.94%)
TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mylan N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 20, 2020) - , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mylan N.V. (NASDAQ: MYL) ("Mylan"...

MYL : 15.73 (-2.66%)
Watch for Mylan Nv to Potentially Pullback After Gaining 3.37% Yesterday

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $16.16 to a high of $17.03. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $16.52...

MYL : 15.73 (-2.66%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar